Le Lézard
Classified in: Health, Science and technology
Subjects: Event, Product/Service, Conference Call, Webcast

MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120


Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a conference call and webcast on March 7, 2024. The program will provide an update on MM120 in Generalized Anxiety Disorder (GAD), including 12-week topline safety, efficacy, and durability results from the Company's Phase 2b trial and results from the Company's Phase 1 pharmacokinetics bridging trial to support the advancement of the MM120 oral dissolving tablet (ODT) formulation into pivotal clinical trials.

A live question and answer session will follow the program.

The event will begin at 8:00 a.m. Eastern Time on Thursday, March 7, 2024. The webcast and slides will be accessible live under "News & Events" on the Investors page of the Company's website at https://ir.mindmed.co/ or by clicking here. A replay of the event will be available on MindMed's website.

About MM120

Lysergide is a synthetic ergotamine belonging to the group of classic psychedelics, which acts as a partial agonist at human serotonin-2A (5-hydroxytryptamine-2A [5-HT2A]) receptors. MindMed is developing MM120 (lysergide D-tartrate), the tartrate salt form of lysergide, for GAD and other psychiatric indications.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine, and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian Cboe Exchange under the symbol MMED.


These press releases may also interest you

at 20:07
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:00
Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 19:54
British Columbia designates Psychotherapy under the Health Professions Act
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

at 19:52
Whitman-Walker Institute Condemns Nationwide Injunction Blocking Federal Nondiscrimination Protections for Transgender People Following a 'Shameful' Decision in Tennessee Case
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...

at 19:22
Baixiang brand Instant Noodles recalled due to undeclared peanut
Product: Instant Noodle Issue: Food - Allergen - Peanut Distribution: AlbertaBritish ColumbiaOntario See the affected products and product photos for this recall Company information Five Continents International Ltd. Telephone: 416-292-6766| Fax:...

at 18:45
Samaritan's Purse Airlifts Relief Supplies to Hurricane-Battered Grenada
The Samaritan's Purse DC-8 departed our hangar in Greensboro, North Carolina, yesterday morning, with a 13-member Disaster Assistance Response Team (DART) and 24 tons of life-saving relief for hurricane-devastated residents of Grenada in the south...

More news about Health...


News published on and distributed by: